Literature DB >> 3768686

Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections.

E K Richfield, A B Young, J B Penney.   

Abstract

[3H]Spiroperidol (spiperone) binding in the presence of mianserin, a serotonin (5-HT2) receptor antagonist, was characterized in rat brain using quantitative autoradiography. All binding parameters were directly determined from film densities. Competition and kinetic studies revealed that [3H]spiroperidol binds to a site having characteristics of the dopamine, D2, receptor in striatum. The general binding parameters were similar to values obtained in homogenate and swabbed section studies except as related to agonist binding and guanine nucleotide sensitivity. Competition studies with dopamine revealed biphasic competition curves with a Kh of 8.23 nM and a Kl of 12.3 microM. The percentage of high-affinity sites was 90%. Guanine nucleotides (1 microM guanylyl-imidodiphosphate) completely converted the high-affinity site to a low-affinity site. Quantitative regional distribution studies revealed high binding in striatum, olfactory tubercle and nucleus accumbens, with lower binding in other dopamine innervated regions including frontal and cingulate cortex. [3H]Spiroperidol was also found to bind to a spirodecanone site with an anatomical localization distinct from the dopamine and serotonin systems and in a region (entorhinal cortex) not previously reported. This report provides a detailed pharmacologic and regional characterization of [3H]spiroperidol binding to D2 receptor in rat brain using quantitative autoradiography to determine all binding parameters. This report also demonstrates an increased percentage of sites in the high-affinity state of the D2 receptor in tissue sections and increased affinity of the guanine regulatory protein for guanine nucleotides.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768686     DOI: 10.1016/0006-8993(86)90013-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease.

Authors:  S W Davies; M Turmaine; B A Cozens; A S Raza; A Mahal; L Mangiarini; G P Bates
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease.

Authors:  J H Cha; A S Frey; S A Alsdorf; J A Kerner; C M Kosinski; L Mangiarini; J B Penney; S W Davies; G P Bates; A B Young
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 3.  Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Authors:  Jan-Peter van Wieringen; Jan Booij; Vladimir Shalgunov; Philip Elsinga; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

4.  Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.

Authors:  J H Cha; C M Kosinski; J A Kerner; S A Alsdorf; L Mangiarini; S W Davies; J B Penney; G P Bates; A B Young
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.

Authors:  Ariel Graff-Guerrero; Matthaeus Willeit; Nathalie Ginovart; David Mamo; Romina Mizrahi; Pablo Rusjan; Irina Vitcu; Philip Seeman; Alan A Wilson; Shitij Kapur
Journal:  Hum Brain Mapp       Date:  2008-04       Impact factor: 5.038

6.  Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.

Authors:  Fernando Caravaggio; Lawrence S Kegeles; Alan A Wilson; Gary Remington; Carol Borlido; David C Mamo; Ariel Graff-Guerrero
Journal:  Synapse       Date:  2016-07-11       Impact factor: 2.562

7.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 8.  Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

Authors:  Matthieu Colom; Benjamin Vidal; Luc Zimmer
Journal:  Front Mol Neurosci       Date:  2019-10-18       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.